Latest news with #AhmadMorsy

Al-Ahram Weekly

Gustave Roussy Egypt starts cancer treatment for UHIS patients in June - Health

The Universal Health Insurance Authority (UHIA) signed an agreement late on Tuesday with the French Gustave Roussy Institute of Oncology to provide its medical services to the Universal Health Insurance System (UHIS) beneficiaries starting next month. In a statement by the UHIA, Dr. Ahmad Morsy, Executive Director of Gustave Roussy International Egypt, expressed his pleasure with this collaboration and confirmed that beneficiaries will receive world-class services in line with the state's vision for a comprehensive and advanced healthcare system. Dr. Morsy added that over 150 cases have been evaluated since the partnership agreement with the Ministry of Health and Population was signed. He noted that the medical team reviewing patients includes Egyptian and French doctors. He added that agreements have been signed with the Egyptian Authority for Unified Procurement to supply all required medications and equipment and with the General Authority for Healthcare to train medical teams. UHIA CEO Mai Farid emphasized that the agreement marks an important step toward enabling UHIS beneficiaries to access specialized cancer treatment services through collaboration with one of the world's most prestigious centres in this field. She affirmed the Authority's ongoing efforts to expand its network of service providers to ensure the highest levels of quality and efficiency. Last year, Egypt turned its oldest hospital, Dar El-Salam General Hospital, established in the early 20th century, into Gustave Roussy International Egypt under a brand licensing agreement with the renowned French Oncology Institute. In 2017, the hospital was converted into a cancer-specialized hospital. Since 2019, the hospital has been a significant part of the presidential initiative for women's health, providing breast examinations for 18,000 women that year alone. Gustave Roussy International Egypt is the first branch of the French institution outside of France. In 2023, Newsweek recognized it as one of the top five cancer institutes in the world. Follow us on: Facebook Instagram Whatsapp Short link: